Press Releases

TissueTech Adds eKare’s Remote Wound Monitoring Solutions to its Host of Virtual Oversight Tools Used in Late-Phase Research of Biologic Candidate TTAX01 to Treat Complex Wagner Grade 3 and 4 Diabetic Foot Ulcers (DFUs)

Virtual technologies minimize risks associated with in-person patient visits, gives investigators the ability to monitor DFU wound healing in real-time via a telehealth platform Miami, FL – October 29, 2020 –TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that they had selected the […]

Encouraging Outcomes Data with Surgical Repair of Chronic, Large, Refractory Macular Holes Using AmnioGraft® Cryopreserved Amniotic Membrane

Bio-Tissue

Miami, FL – September 14, 2020 — Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of Cryopreserved Amniotic Membrane and Umbilical Cord tissue allografts for ocular surface disease, announced today the case series outcome of surgical repair of large macular holes using AmnioGraft Cryopreserved Amniotic Membrane. Results have shown that the placement of AmnioGraft may be a feasible alternative to conventional surgical methods to improve anatomic and visual outcomes.1

TissueTech to Collaborate with Johns Hopkins University-based Investigators to Study the Use of Cryopreserved Amniotic Membrane and Umbilical Cord for the Non-Opioid Treatment of Post-Surgical Pain

Amniox Medical

Miami, FL – August 17, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that Yun Guan, MD, PhD, professor of anesthesiology and critical care medicine, and professor of neurological surgery at the Johns Hopkins University School of Medicine, has been awarded a 5-year R01 grant from the National Institutes of Health (NIH) for a study titled “Birth Tissue Products for Non-opioid Treatment of Post-surgical Pain.” Dr. Guan and his team will study the efficacy and molecular mechanism, thereby human birth tissue promotes wound healing and suppresses pain after surgical procedures. TissueTech will serve as a sub-contractor on the project.

PROKERA® Slim Corneal Bandage Now Approved in Taiwan for Treatment of Ocular Wounds

Bio-Tissue

Provides Taiwan eye care professionals with a well-established product to support healing in corneal-involved dry eye, keratitis, recurrent corneal erosions, and other ocular surface diseases Miami, FL – August 5, 2020 — Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of human birth tissue products for ocular surface disease and disorders, […]

SAWC Spring Meeting Features Symposium on Promising Advancements in the Treatment of Complex Wounds

Amniox Medical

Virtual symposium showcases results from study follow-up in which 86.2% of patients achieved complete closure of Wagner Grade 3-4 Diabetic Foot Ulcers (DFUs) with TTAX01 Cryopreserved Umbilical Cord allograft. Miami, FL – July 27, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, […]

Amniox Announces Initiation for First of Two Phase 3 Clinical Trials of Cryopreserved Umbilical Cord TTAX01 Allograft to Treat Complex Wagner Grade 3-4 Diabetic Foot Ulcers

Amniox Medical

Company’s first biologic license application (BLA) candidate TTAX01 to enter Investigational New Drug (IND) Phase 3 Trials for Diabetic Foot Ulcer (DFU) indication as first biologic product to seek FDA approval for complex Wagner Grade 3 and 4 DFUs Miami, FL – June 30, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and […]

One-year Follow-up Study Results Find Cryopreserved Umbilical Cord Allograft for Treatment of Wagner Grade 3-4 Diabetic Foot Ulcers to be Safe with Higher than Expected Rates of Healing

Amniox Medical

86.2% of patients achieved complete closure with use of TTAX01 in the follow-up study, up from 50% confirmed closure during the original 16-week trial. Miami, FL – June 1, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from […]

Pilot Study Shows Adjunctive Use of Umbilical Cord Allograft May Improve Clinical and Functional Outcomes Following Arthroscopic Repair of Talar Osteochondral Defects

Amniox Medical

Cryopreserved umbilical cord allograft is a novel treatment option due to its unique properties promoting a regenerative wound healing environment   Miami, FL – May 18, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from a prospective, single-center, […]

First Annual National Mechanical Dry Eye Day is May 19, 2020

Bio-Tissue

Inaugural day to bring awareness to Mechanical Dry Eye, one of the most overlooked and often misdiagnosed age-related eye conditions Miami, FL – May 4, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of human birth tissue products for ocular surface disease and disorders, has announced that the first-ever […]

TissueTech Announces Additional Professional Education Events for Physicians and Staff During April, May, and June

TissueTech

Live webinars focus on Ophthalmic, Wound Care, Podiatry, and Orthopedic Indications using Cryopreserved Human Birth Tissue Miami, Fla. – April 21, 2020 – TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue products and parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., announced today that they have rolled […]

Archives

  • 2020
  • 2019
  • 2018